Package 70264-026-02

{"route": ["ORAL"], "spl_id": "43c8b9ec-31e8-554f-e063-6294a90a0964", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["362O9ITL9D", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1243679"], "spl_set_id": ["2cbf7954-b28f-4d7b-b142-6c6c5c58b25d"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["R J General Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "50 POUCH in 1 BOX (70264-026-02)  / 2 TABLET, COATED in 1 POUCH", "package_ndc": "70264-026-02", "marketing_start_date": "20210501"}], "brand_name": "TYLENOL SINUS SEVERE", "product_id": "70264-026_43c8b9ec-31e8-554f-e063-6294a90a0964", "dosage_form": "TABLET, COATED", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "70264-026", "generic_name": "ACETAMINOPHEN", "labeler_name": "R J General Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "TYLENOL SINUS SEVERE", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "GUAIFENESIN", "strength": "200 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210501", "listing_expiration_date": "20261231"}